Vaginal versus oral Misoprostol for second–trimester pregnancy terminatio

Phase 2

• Conditions: Second trimester termination of pregnancy.; Termination of pregnancy, fetus and newborn

• Registration Number: IRCT201103281760N11
• Lead Sponsor: Vice Chancellor for Research and Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Pregnant women Hospitalized in the second–trimester (24-14 weeks gestation) for abortion with single pregnancy, parity conditions 1 to 3, without pain, uterine infection and dilatation are less than 2cm. Exclusion criteria: Multiple pregnancy, Chorioamnionits previous uterus incision, parity over 3, patients with asthma, liver, kidney and heart disease.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Abortion. Timepoint: The start of the intervention up to 24 hours. Method of measurement: Clinical examinations.

Secondary Outcome Measures

Name	Time	Method
umber of tablets consumed. Timepoint: The start of the intervention up to 24 hours. Method of measurement: Clinical examinations.;Possible Complications. Timepoint: The start of the intervention up to 24 hours. Method of measurement: Clinical examinations.;Amount of bleeding. Timepoint: The start of the intervention up to 24 hours. Method of measurement: Clinical examinations.;The need for curettage. Timepoint: The start of the intervention up to 24 hours. Method of measurement: Clinical examinations.